STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Factors of COVID-19
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:2 publications
Grant number: COV20_00181
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
José María Aguado GarcíaResearch Location
SpainLead Research Institution
FUNDACION INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBREResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Individuals with multimorbidityOtherUnspecified
Occupations of Interest
Unspecified
Abstract
WPs]) over 12 months: WP0 (cross-sectional): constitution of a prospective cohort of patients with COVID-19, clinical characterization and collection of biological samples (HU12O, HUFJD / IIS-FJD, HCUVA, HUIE); WP1 (clinical): predictive model based on clinical and biochemical variables (HU12O); WP2 (immune): immune response to SARS-CoV-2 (HU12O, HCUVA); WP3 (genomic): host genetic prognostic markers (HUFJD / IIS-FJD, HCUVA); WP4 (immunosuppressed): COVID-19 in oncohematological and transplant patients (HU12O, HUFJD, HCUVA); WP5 (therapeutic): response to antiviral and immunomodulatory treatment (HU12O); WP6 (bioethical): socio-economic analysis and ethical repercussions (HUIE, HUFJD, HCUVA); and WP7 (virological): viral dynamics and spectrum of SARS-CoV-2 mutants.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC